Development of sulfonamide AKT PH domain inhibitors
- 1 February 2011
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 19 (6) , 2046-2054
- https://doi.org/10.1016/j.bmc.2011.01.049
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (RO1 CA 061015, P30 CA 23074)
This publication has 38 references indexed in Scilit:
- Small molecule inhibition of phosphatidylinositol-3,4,5-triphosphate (PIP3) binding to pleckstrin homology domainsProceedings of the National Academy of Sciences, 2010
- Tirucallic Acids Are Novel Pleckstrin Homology Domain-Dependent Akt Inhibitors Inducing Apoptosis in Prostate Cancer CellsMolecular Pharmacology, 2010
- A Small Molecule Inhibits Akt through Direct Binding to Akt and Preventing Akt Membrane TranslocationJournal of Biological Chemistry, 2010
- Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domainBioorganic & Medicinal Chemistry, 2009
- Probing Akt-inhibitor interaction by chemical cross-linking and mass spectrometryJournal of the American Society for Mass Spectrometry, 2009
- In vitro and In vivo Activity of Novel Small-Molecule Inhibitors Targeting the Pleckstrin Homology Domain of Protein Kinase B/AKTCancer Research, 2009
- Class I PI3K in oncogenic cellular transformationOncogene, 2008
- Benzene Polyphosphates as Tools for Cell Signalling: Inhibition of Inositol 1,4,5‐Trisphosphate 5‐Phosphatase and Interaction with the PH Domain of Protein Kinase BαChemBioChem, 2008
- Comprehensive Identification of PIP3-Regulated PH Domains from C. elegans to H. sapiens by Model Prediction and Live ImagingMolecular Cell, 2008
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR ComplexScience, 2005